会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • MUCOMIMETIC COMPOSITIONS AND USES THEREFORE
    • MUCOMIMETIC COMPOSITIONS及其用途
    • WO2010038129A1
    • 2010-04-08
    • PCT/IB2009/006972
    • 2009-09-28
    • CHEMISCHES INSTITUT SCHAEFER AGSCHAEFER, Rolf
    • SCHAEFER, Rolf
    • A61K9/00A61K9/06A61K31/728A61K47/02A61K47/34A61K47/36A61K47/38A61L12/14A61K31/785
    • A61K9/0048
    • The present invention relates to mucomimetic and ophthalmic solutions comprising a cationic polymeric antimicrobial agent such as polyaminopropyl biguanide and a magnesium, calcium or magnesium/calcium complex of an anionic polymer such as hyaluronate, alginate, carboxymethyl cellulose, chondroitin sulfate or mixtures thereof. In specific embodiments, the solutions include additional components such as a surfactant, preferably polysorbate 20, a viscosity-modifying agent, preferably hydroxypropylmethyl cellulose, carboxymethyl cellulose or hydroxyethyl cellulose, a tonicity agent and a buffer. The solutions are biocompatible with and are highly comfortable when administered to mucous membranes, including those of the eye, as well as are effective disinfectants.
    • 本发明涉及包含阳离子聚合抗微生物剂如聚氨基丙基双胍的阴模溶液和眼用溶液以及阴离子聚合物如透明质酸盐,藻酸盐,羧甲基纤维素,硫酸软骨素或其混合物的镁,钙或镁/钙络合物。 在具体实施方案中,溶液包括另外的组分,例如表面活性剂,优选聚山梨酯20,粘度调节剂,优选羟丙基甲基纤维素,羧甲基纤维素或羟乙基纤维素,张度剂和缓冲剂。 当给予粘膜(包括眼睛的那些)以及有效的消毒剂时,溶液是生物相容的并且是高度舒适的。
    • 5. 发明申请
    • CEFUROXIME SAFETY DELIVERY SYSTEM
    • CEFUROXIME安全递送系统
    • WO2012110471A1
    • 2012-08-23
    • PCT/EP2012/052442
    • 2012-02-14
    • CHEMISCHES INSTITUT SCHAEFER AGSCHAEFER, Rolf
    • SCHAEFER, Rolf
    • A61K9/00A61M5/178A61M5/315A61J1/20A61M5/19A61M5/24
    • A61J1/2096A61J1/00A61J1/20A61J1/2089A61K9/0048A61K31/546A61M5/00A61M5/178A61M5/19A61M5/2448A61M5/31596F16D43/18
    • The present invention relates to safety delivery systems for intracameral administration of an appropriate dose of cefuroxime subsequent to cataract and other eye surgery. A preferred embodiment of an cefuroxime safety delivery system according to the invention comprises (a) a perforable sterile vial sterile-filled with a measured amount of cefuroxime, (b) a reconstitution syringe with a male luer fitting sterile-filled with 0.1 ml of isotonic salt solution per mg cefuroxime in the perforable vial and a vial adapter with a female luer fitting or one or more needles with female luer fitting, and (c) one or more sterilized delivery syringes with male luer fitting, each delivery syringe being capable of holding at least 0.1 ml of ejectable liquid and containing a marking indicating a fill volume of 0.1 ml of ejectable liquid.
    • 本发明涉及用于在白内障和其它眼睛手术之后的适当剂量的头孢呋辛的腔内施用的安全递送系统。 根据本发明的头孢呋辛安全递送系统的优选实施方案包括(a)无菌填充有测量量的头孢呋辛的穿孔无菌小瓶,(b)具有无菌填充有0.1ml等渗剂的雄性鲁尔配方的重构注射器 在可穿孔小瓶中的每mg头孢呋辛盐溶液和具有阴性鲁尔接头或具有阴性鲁尔接头的一个或多个针的小瓶适配器,以及(c)一个或多个带有雄性鲁尔接头的灭菌递送注射器,每个输送注射器能够保持 至少0.1ml的可喷射液体,并含有一个标记,指示填充体积为0.1ml的可喷射液体。